5-cyclopropyl-4-ethynyl-1-methyl-1{H}-pyrazole, 5g

Chlorotripyrrolidinophosphonium hexafluorophosphate, 98.0%, 100g

6-Nitro-3,4-dihydro-2H-benzo[b][1,4]oxazine, 95.0%, 10g

1-(Quinazolin-4-yl)piperidin-4-amine, 1g

cis-1,3-Cyclohexanediol>98.0%(GC)1g

(2R,3R,4S,5R)-2-(6-((3-Hydroxybenzyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 97.0%, 250mg

1,2-Bis(pyridin-4-ylmethylene)hydrazine, 95%, 1g

1-{[4-fluoro-2-(trifluoromethyl)phenyl]methyl}-3-nitro-1H-pyrazole, 95.0%, 1g

Boc-Arg(Tos)-OH, 95%, 5g

2-[Difluoro-(3,4,5-trifluorophenoxy)methyl]-1,3-difluoro-5-(4-propylphenyl)benzene, 97%, 100g

[2,2':6',2''-Terpyridine]-4'-carboxylic acid, 95.0%, 250mg

3-(PIPERIDIN-1-YLMETHYL)-1H-INDOLE-6-CARBONITRILE, 95.0%, 5g

Single-channel microliter pipette Pipetman® G, 1 to 10 µl, P10G, 1 piece